Overview

Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy

Status:
Completed
Trial end date:
2018-09-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if giving reolysin in combination with docetaxel or pemetrexed can offer better results than standard therapy with docetaxel or pemetrexed alone.
Phase:
Phase 2
Details
Lead Sponsor:
Canadian Cancer Trials Group
Collaborator:
Oncolytics Biotech
Treatments:
Docetaxel
Pemetrexed